Venture Capital

As Mark Adams retires, Penguin Solutions appoints Kash Shaikh, a proven AI and SaaS leader, to accelerate its push into the booming enterprise AI market.

Atlantic International hires veteran CFO Kevin J. Murphy to integrate its massive Circle8 acquisition and navigate a complex financial landscape.

Once valued at $3.3B, the healthtech giant seeks Chapter 11 protection, a stark warning for the post-pandemic digital health industry.

National firm MNP joins forces with Vancouver's Sierra Accounting, a strategic move to capture the booming media and entertainment sector in British Columbia.

A new AI platform is bringing Pentagon-style wargaming to the boardroom, simulating competitive futures to help companies out-maneuver rivals.

A new report projects massive growth in the plant-based sector, driven by tech innovation, corporate investment, and a worldwide shift in consumer habits.

Beyond M&A, ACROBiosystems' bioSeedin summit redefines growth, connecting global capital with biotech innovation in a new era of strategic partnerships.

Tom Brady's collectibles empire expands with a new flagship store in San Francisco, betting big on experiential retail during the Super Bowl LX weekend.

MAPS and Columbia University launch a landmark study into MDMA-assisted couples therapy, seeking to turn decades of underground practice into a safe future.

Beyond retail, Pacsun is investing in the next generation of musicians, using co-creation and strategic partnerships to build authentic cultural relevance.

Madison Square Garden and Infosys deepen their tech partnership, rebranding the iconic theater and promising new AI-driven experiences for Knicks and Rangers fans.

The iconic F1 team is integrating Anthropic's Claude AI to navigate 2026's massive rule changes, aiming to outthink rivals and return to the top.

From automated bookings to data-driven operations, a new tech tide is rising, promising greater efficiency for operators and better experiences for boaters.

With its largest fund yet, the firm is doubling down on breakthrough biotech and medtech, signaling strong investor faith in deep science innovation.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.

Following a federal probe into a Waymo robotaxi hitting a child, the Teamsters union calls for an indefinite ban, escalating the battle over AV safety and jobs.

Madison Square Garden's theater is renamed as part of an expanded deal, leveraging AI to redefine the fan experience for sports and entertainment.

Shanghai's AI EdTech innovator Jinxin faces a potential Nasdaq delisting after its stock plummets, putting its high-tech vision against market reality.

Forrester recognizes Kaltura for its AI, signaling a market shift toward hyper-personalized events, immersive avatars, and long-term content value.